Achilles Therapeutics plc
ACHL
$1.48
$0.010.68%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 86.05M | 95.11M | 112.32M | 131.54M | 140.14M |
| Total Receivables | 21.79M | 18.35M | 15.73M | 10.35M | 9.60M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.47M | 2.23M | 1.58M | 1.76M | 2.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.32M | 2.13M | 1.80M | 1.98M | 2.96M |
| Total Current Assets | 111.63M | 117.82M | 131.43M | 145.63M | 155.49M |
|
|
|||||
| Total Current Assets | 111.63M | 117.82M | 131.43M | 145.63M | 155.49M |
| Net Property, Plant & Equipment | 9.23M | 11.12M | 12.07M | 13.54M | 16.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.82M | 2.25M | 2.24M | 2.28M | 3.19M |
| Total Assets | 122.68M | 131.19M | 145.74M | 161.46M | 175.34M |
|
|
|||||
| Total Accounts Payable | 4.25M | 2.87M | 3.31M | 5.63M | 5.35M |
| Total Accrued Expenses | 9.36M | 6.12M | 5.58M | 6.86M | 7.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.62M | 4.21M | 3.63M | 3.54M | 4.62M |
| Total Finance Division Other Current Liabilities | 1.24M | 1.11M | 1.14M | 965.00K | 965.00K |
| Total Other Current Liabilities | 1.24M | 1.11M | 1.14M | 965.00K | 965.00K |
| Total Current Liabilities | 18.47M | 14.30M | 13.65M | 17.00M | 18.18M |
|
|
|||||
| Total Current Liabilities | 18.47M | 14.30M | 13.65M | 17.00M | 18.18M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 258.00K | 584.00K | 1.08M | 2.73M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.07M | 1.16M | 1.16M | 1.02M | 941.00K |
| Total Liabilities | 19.54M | 15.71M | 15.39M | 19.09M | 21.85M |
|
|
|||||
| Common Stock & APIC | 419.15M | 417.97M | 416.66M | 415.26M | 413.87M |
| Retained Earnings | -308.20M | -288.61M | -272.23M | -259.95M | -241.32M |
| Treasury Stock & Other | -7.81M | -13.89M | -14.08M | -12.94M | -19.06M |
| Total Common Equity | 103.14M | 115.48M | 130.35M | 142.37M | 153.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 103.14M | 115.48M | 130.35M | 142.37M | 153.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 103.14M | 115.48M | 130.35M | 142.37M | 153.49M |
|
|
|||||
